Cloud-clone
SKU:LAC285Ra71
Biotin-Linked Polyclonal Antibody to Anterior Gradient 2 (AGR2)
Biotin-Linked Polyclonal Antibody to Anterior Gradient 2 (AGR2)
Couldn't load pickup availability
Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.
Product No.
LAC285Ra71
Organism Species
Rattus norvegicus (Rat).
Source
Antibody labeling
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
Biotin
Original Antibody
n/a
Buffer Formulation
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Traits
Liquid
Concentration
500µg/mL
Organism Species More
n/a
Applications
WB; IHC; ICC.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against AGR2. It has been selected for its ability to recognize AGR2 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
|
Magazine |
Citations |
|
Cancer Biomarkers |
Serum AGR2 as an early diagnostic and postoperative prognostic biomarker of human lung adenocarcinoma MetaPress: n7137r6271u54118 |
|
Molecular & Cellular Proteomics |
Integrated Proteomic Profiling of Cell Line Conditioned Media and Pancreatic Juice for the Identification of Pancreatic Cancer Biomarkers PubMed: PMC3205865 |
|
Prostate. |
Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype Pubmed: 22911164 |
|
BMC Cancer. |
Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9 Pubmed: 24007603 |
|
Clinical Cancer Research |
Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer Pubmed:25239611 |
|
PLoS One |
AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection PubMed: 25875093 |
|
Clinical Neurology and Neurosurgery |
Serum AGR2 as a useful biomarker for pituitary adenomas S0303846717300045 |
|
Oncotarget |
Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2) Pubmed:29937991 |
|
Int J Oncol |
Anterior gradient protein 2 is a marker of tumor aggressiveness in breast cancer and favors chemotherapy‑induced senescence escape 34913074 |
|
International Journal of Cancer |
Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer Pubmed:35689436 |
|
Catalog No. |
Related products for research use of Rattus norvegicus (Rat) Organism species |
Applications (RESEARCH USE ONLY!) |
|
RPC285Ra01 |
Positive Control; Immunogen; SDS-PAGE; WB. |
|
|
PAC285Ra01 |
WB; IHC; ICC; IP. |
|
|
LAC285Ra71 |
Biotin-Linked Polyclonal Antibody to Anterior Gradient 2 (AGR2) |
WB; IHC; ICC. |
|
MAC285Ra22 |
WB; IHC; ICC; IP. |
|
|
MAC285Ra23 |
WB; IHC; ICC; IP. |
|
|
MAC285Ra21 |
WB; IHC; ICC; IP. |
|
|
MAC285Ra27 |
WB; IHC; ICC; IP. |
|
|
MAC285Ra25 |
WB; IHC; ICC; IP. |
|
|
KSC285Ra01 |
Main materials for "Do It(ELISA Kit) Yourself" |
Share
